Search - tctmd.com

Displaying 641 - 660 of 976

Sort: Relevancy | Date

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Caitlin E. Cox

August 12, 2013

News Daily News

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Jason Kahn

August 05, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Meta-Analysis Provides Little Closure to PFO-Stroke Debate

Jason Kahn

July 24, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

Advertisement

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Contemporary ZES Perform Well in Treating In-Stent Restenosis

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Meta-Analysis Provides Little Closure to PFO-Stroke Debate

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content